Hello network!
We are pleased to announce the release of the Horizon Scanning Report 2021, where Omakase is collaborating with ORPHAR-SEFH to screen the arrival to market of upcoming orphan drugs in the short and medium term.
This years’ report is split in two between oncological and non-oncological drugs and is available for download in the webpage of ORPHAR-SEFH.
You can access to it through the following link: https://gruposdetrabajo.sefh.es/orpharsefh/index.php/proyectos-del-grupo